GEN Exclusives

More »

GEN News Highlights

More »
Nov 5, 2007

Advanced Proteome Therapeutics and Atreus Partner to Advance Protein-In Vivo Imaging Agents

  • Advanced Proteome Therapeutics (APT) and Atreus Pharmaceuticals are exploring the development of protein-in vivo imaging agents. The collaboration will use APT’s advanced site-directed peptide modification techniques.

    The first product is intended for imaging the earliest changes associated with rheumatoid arthritis. The resulting technology is expected to have clinical applications in the diagnosis and management of early rheumatoid arthritis.

    Under the agreement, Atreus will have the exclusive right to commercialize the jointly developed agents in return for revenue-sharing payments to APT. Atreus will provide technical, clinical, and market expertise to the program as well as intellectual property rights.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?